{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:01:43Z","timestamp":1790805703780,"version":"4.1.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/fpc.0000000000000153","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T08:51:28Z","timestamp":1434617488000},"page":"402-411","source":"Crossref","is-referenced-by-count":87,"title":["Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions"],"prefix":"10.1097","volume":"25","author":[{"given":"Thachanan","family":"Kongpan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surakameth","family":"Mahasirimongkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parinya","family":"Konyoung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirimas","family":"Kanjanawart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pansu","family":"Chumworathayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuanjun","family":"Wichukchinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runglak","family":"Kidkeukarun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suphanlinee","family":"Preechakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usanee","family":"Khunarkornsiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warawut","family":"Bamrungram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Butsaban","family":"Supharatwattanakun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piroon","family":"Mootsikapun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supanida","family":"Kwangsukstid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukanda","family":"Denjanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suda","family":"Vannaprasaht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Watcharee","family":"Rungapiromnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wimon","family":"Suwankesawong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wongwiwat","family":"Tassaneeyakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wichittra","family":"Tassaneeyakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210213","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/03009748709102191","article-title":"Clinical aspects of skin reactions to NSAIDs.","volume":"65","author":"Roujeau","year":"1987","journal-title":"Scand J Rheumatol Suppl"},{"key":"R2-5-20210213","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs.","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"R3-5-20210213","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4103\/0022-3859.81865","article-title":"Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.","volume":"57","author":"Barvaliya","year":"2011","journal-title":"J Postgrad Med"},{"key":"R4-5-20210213","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":". Medical genetics: a marker for Stevens-Johnson syndrome.","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"R5-5-20210213","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":". HLA-B5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"R6-5-20210213","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":". Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"R7-5-20210213","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","article-title":". A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.","volume":"18","author":"Lonjou","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"R8-5-20210213","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2217\/14622416.9.11.1617","article-title":". HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis.","volume":"9","author":"Kaniwa","year":"2008","journal-title":"Pharmacogenomics"},{"key":"R9-5-20210213","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/FPC.0b013e328330a3b8","article-title":". Strong association between HLA-B5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.","volume":"19","author":"Tassaneeyakul","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"R10-5-20210213","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1528-1167.2010.02533.x","article-title":". Association between HLA-B1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population.","volume":"51","author":"Tassaneeyakul","year":"2010","journal-title":"Epilepsia"},{"key":"R11-5-20210213","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/FPC.0b013e32834282b8","article-title":". Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans.","volume":"21","author":"Kang","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"R12-5-20210213","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1093\/ndt\/gfr060","article-title":". HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency.","volume":"26","author":"Jung","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R13-5-20210213","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","article-title":". Association between presence of HLA-B5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.","volume":"359","author":"Mallal","year":"2002","journal-title":"Lancet"},{"key":"R14-5-20210213","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":". HLA-B5701 screening for hypersensitivity to abacavir.","volume":"358","author":"Mallal","year":"2008","journal-title":"N Engl J Med"},{"key":"R15-5-20210213","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/archderm.1987.01660330082014","article-title":"Genetic susceptibility to toxic epidermal necrolysis.","volume":"123","author":"Roujeau","year":"1987","journal-title":"Arch Dermatol"},{"key":"R16-5-20210213","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11147","article-title":". Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.","volume":"486","author":"Illing","year":"2012","journal-title":"Nature"},{"key":"R17-5-20210213","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tox.2004.12.022","article-title":"Clinical heterogeneity of drug hypersensitivity.","volume":"209","author":"Roujeau","year":"2005","journal-title":"Toxicology"},{"key":"R18-5-20210213","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":". A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R19-5-20210213","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":". ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis.","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"R20-5-20210213","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1399-0039.2010.01448.x","article-title":"HLA class I and II alleles and haplotypes in ethnic Northeast Thais.","volume":"75","author":"Romphruk","year":"2010","journal-title":"Tissue Antigens"},{"key":"R21-5-20210213","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0190-9622(92)70082-Q","article-title":"Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus.","volume":"26","author":"Saiag","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"R22-5-20210213","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-010611-134701","article-title":"Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex.","volume":"52","author":"Bharadwaj","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R23-5-20210213","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1533-2500.2011.00479.x","article-title":". HLA-B1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.","volume":"12","author":"Kulkantrakorn","year":"2012","journal-title":"Pain Pract"},{"key":"R24-5-20210213","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2217\/pgs.09.162","article-title":". Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.","volume":"11","author":"Hung","year":"2010","journal-title":"Pharmacogenomics"},{"key":"R25-5-20210213","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0378-4347(94)00232-0","article-title":"Isolation, identification and determination of sulfamethoxazole and its known metabolites in human plasma and urine by high-performance liquid chromatography.","volume":"658","author":"Vree","year":"1994","journal-title":"J Chromatogr B Biomed Appl"},{"key":"R26-5-20210213","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0090-9556(25)08967-6","article-title":"Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity.","volume":"19","author":"Cribb","year":"1991","journal-title":"Drug Metab Dispos"},{"key":"R27-5-20210213","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/sj.bjp.0702453","article-title":"Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity.","volume":"126","author":"Naisbitt","year":"1999","journal-title":"Br J Pharmacol"},{"key":"R28-5-20210213","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.bjp.0704074","article-title":"Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo.","volume":"133","author":"Naisbitt","year":"2001","journal-title":"Br J Pharmacol"},{"key":"R29-5-20210213","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1755-8794-5-32","article-title":"Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIVAIDS patients.","volume":"5","author":"Wang","year":"2012","journal-title":"BMC Med Genomics"},{"key":"R30-5-20210213","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/clpt.1991.3","article-title":"Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions.","volume":"49","author":"Rieder","year":"1991","journal-title":"Clin Pharmacol Ther"},{"key":"R31-5-20210213","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00002030-199403000-00006","article-title":"Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients.","volume":"8","author":"Carr","year":"1994","journal-title":"AIDS"},{"key":"R32-5-20210213","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00008571-199712000-00011","article-title":"Glutathione S-transferase (GSTM1) null genotype and sulphonamide intolerance in acquired immunodeficiency syndrome.","volume":"7","author":"Delomenie","year":"1997","journal-title":"Pharmacogenetics"},{"key":"R33-5-20210213","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0006-2952(91)90334-2","article-title":"Glutathione transferase mu deficiency is not a marker for predisposition to sulphonamide toxicity.","volume":"42","author":"Riley","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"R34-5-20210213","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/00008571-200011000-00005","article-title":"Association analysis of drug metabolizing enzyme gene polymorphisms in HIV-positive patients with co-trimoxazole hypersensitivity.","volume":"10","author":"Pirmohamed","year":"2000","journal-title":"Pharmacogenetics"},{"key":"R35-5-20210213","doi-asserted-by":"crossref","first-page":"e76211","DOI":"10.1371\/journal.pone.0076211","article-title":"Sulfamethoxazole induces a switch mechanism in T cell receptors containing TCRVbeta20-1, altering pHLA recognition.","volume":"8","author":"Watkins","year":"2013","journal-title":"PLoS One"},{"key":"R36-5-20210213","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1747.2002.01622.x","article-title":". Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis.","volume":"118","author":"Nassif","year":"2002","journal-title":"J Invest Dermatol"},{"key":"R37-5-20210213","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":". Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.","volume":"114","author":"Nassif","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"R38-5-20210213","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.tpj.6500356","article-title":". A marker for Stevens-Johnson syndrome... ethnicity matters.","volume":"6","author":"Lonjou","year":"2006","journal-title":"Pharmacogenomics J"},{"key":"R39-5-20210213","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/j.1528-1167.2010.02766.x","article-title":". HLA-B1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.","volume":"51","author":"Kaniwa","year":"2010","journal-title":"Epilepsia"},{"key":"R40-5-20210213","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.eplepsyres.2011.08.010","article-title":". Adverse Drug Reaction Research Group in Korea. Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans.","volume":"97","author":"Kim","year":"2011","journal-title":"Epilepsy Res"},{"key":"R41-5-20210213","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/hmg\/ddq537","article-title":". Genome-wide association study identifies HLA-A3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population.","volume":"20","author":"Ozeki","year":"2011","journal-title":"Hum Mol Genet"},{"key":"R42-5-20210213","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":". HLA-A3101 and carbamazepine-induced hypersensitivity reactions in Europeans.","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0000000000000153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T14:40:47Z","timestamp":1748443247000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201508000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000153","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}